Saleh, M., Saad, E., Machaalani, M., Ascione, L., Moura Barrios, P., El Masri, J., . . . Choueiri, T. (2025). 132P Genomic determinants of leukocyte homeostasis predict responses to immune checkpoint blockade (ICB) monotherapy versus combination therapy in patients (pts) with cancer. Annals of Oncology, 36, S256. https://doi.org/10.1016/j.annonc.2025.08.566
Chicago Style (17th ed.) CitationSaleh, M., et al. "132P Genomic Determinants of Leukocyte Homeostasis Predict Responses to Immune Checkpoint Blockade (ICB) Monotherapy Versus Combination Therapy in Patients (pts) with Cancer." Annals of Oncology 36 (2025): S256. https://doi.org/10.1016/j.annonc.2025.08.566.
MLA (9th ed.) CitationSaleh, M., et al. "132P Genomic Determinants of Leukocyte Homeostasis Predict Responses to Immune Checkpoint Blockade (ICB) Monotherapy Versus Combination Therapy in Patients (pts) with Cancer." Annals of Oncology, vol. 36, 2025, p. S256, https://doi.org/10.1016/j.annonc.2025.08.566.